Volume: 5 Issue: 1

1. Hormonal control of clucose metabolism in liver transplantation in dogs. Page:157—164
2. Determination of flushing volume in cannine orthotopic liver transplantation. Page:151—156
3. The role of NK cell in heart-lung transplanted mice. Page:143—149
4. Effect of donor and recipient genotype upon the heart-lung transplantation in mice. Page:135—142
5. A case of tuberculosis occurred on the graft kidney. Page:129—133
6. Spontaneous renal allograft rupture. Page:123—127
7. Acute pancreatitis after renal transplantation. Page:117—122
8. Renal transplantation using ileal conduit: case report. Page:113—116
9. Impact of early graft function on the long-term outcome of living donor kidney transplant(TLX). Page:109—111
10. Pelvis dilatation and mucosal thickening of transplanted kidney: comparative study of resistive index and ultrasonographic finding. Page:101—107
11. Kidney trnasplantation for diabetic nephropathy. Page:95—99
12. Autoimmune hemolytic anemia after renal transplantation. Page:91—94
13. Herpes simplex virus and varicella zoster virus infection in renal transplant recipients. Page:83—89
14. Hyperuricemia in renal transplantation recipients. Page:75—82
15. The clinical charateristics of tuberculosis in renal transplant recipients. Page:69—74
16. Renal transplantation is not contraindicated in hepatitis B surface antigen positive patients. Page:63—67
17. Use of elderly living related donors in renal transplantation(TLX). Page:59—61
18. The quality of life of ESRD patient development of a tool and comparison between transplants dialysis patients. Page:51—58
19. Kidney trnasplantation for diabetic nephropathy. Page:95—99
20. Is HLA-DRW6 antigen matching necessary in living donor renal transplant (TLX)?. Page:47—50
21. Autoimmune hemolytic anemia after renal transplantation. Page:91—94
22. The effect of HLA mismatching on living kidney graft survivals. Page:35—45
23. Herpes simplex virus and varicella zoster virus infection in renal transplant recipients. Page:83—89
24. Single center experience of 600 living donor renal transplant: univariate analysis of risk factors influencing allograft outcome. Page:27—33
25. Hyperuricemia in renal transplantation recipients. Page:75—82
26. A clinical analysis of 72 renal transplantations. Page:17—26
27. The clinical charateristics of tuberculosis in renal transplant recipients. Page:69—74
28. The graft survival rates and stability of renal allograft function associate with cyclosporine immunosuppressive therapy. Page:1—15
29. Renal transplantation is not contraindicated in hepatitis B surface antigen positive patients. Page:63—67
30. Use of elderly living related donors in renal transplantation(TLX). Page:59—61
31. The quality of life of ESRD patient development of a tool and comparison between transplants dialysis patients. Page:51—58
32. Is HLA-DRW6 antigen matching necessary in living donor renal transplant (TLX)?. Page:47—50
33. The effect of HLA mismatching on living kidney graft survivals. Page:35—45
34. Single center experience of 600 living donor renal transplant: univariate analysis of risk factors influencing allograft outcome. Page:27—33
35. A clinical analysis of 72 renal transplantations. Page:17—26
36. The graft survival rates and stability of renal allograft function associate with cyclosporine immunosuppressive therapy. Page:1—15